Nemolizumab: New Effective Drug for Management of Atopic Dermatitis, Study Finds Dr. Garima Soni21 Aug 2024 9:30 PM ISTUSA: Nemolizumab, a newly developed medication for atopic dermatitis, is effective when combined with topical corticosteroids (TCS) or topical...
Use of spironolactone for dermatological conditions may not increase risk of breast or uterine tumors: Study Dr. Shravani Dali21 Aug 2024 5:45 AM ISTUse of spironolactone for dermatological conditions may not increase the risk of breast or uterine tumours suggests a study published in the Journal...
Mineral sunscreen moisturizer effective option for for improving photodamage among patients across all skin tones: Study Dr Riya Dave19 Aug 2024 11:30 PM ISTResearchers have found that a new 100% mineral sunscreen moisturizer (MSM) with broad-spectrum SPF 50 is both effective and well-tolerated across all...
Tirbanibulin Proven Safe and Tolerable for Larger Actinic Keratosis Fields, Expanding Treatment Options: Study Deepanshi Bhatnagar18 Aug 2024 9:45 PM ISTUSA: Tirbanibulin ointment, at a 1% concentration, demonstrates good safety and effectiveness for treating actinic keratosis (AK) on areas up...
Dupilumab Shows Promising Results for Hair Regrowth in Pediatric Alopecia Areata, with No New Safety Concerns: Study Medha Baranwal17 Aug 2024 9:30 AM ISTUSA: A real-world, single-center observational study revealed that dupilumab significantly enhanced hair regrowth in pediatric patients with alopecia...
Dupilumab use among pediatric atopic dermatitis patients may improve comorbid asthma, finds study Dr. Shravani Dali16 Aug 2024 8:00 AM ISTDupilumab use among pediatric atopic dermatitis patients may improve comorbid asthma, finds a study published in the Pediatric Allergy and...
All commonly prescribed oral antibiotics tied to increased risk of serious cutaneous adverse drug reactions leading to an ED visit: JAMA Dr. Shravani Dali13 Aug 2024 10:30 PM ISTAll commonly prescribed oral antibiotics tied to increased risk of serious cutaneous adverse drug reactions leading to an ED visit suggests a study...
Cendakimab effective, safe, and well-tolerated in patients with moderate to severe atopic dermatitis: JAMA Dr Riya Dave13 Aug 2024 8:30 AM ISTResearchers have found that cendakimab, an interleukin-13 (IL-13) targeting monoclonal antibody, significantly reduces the severity of atopic...
Oral Antibiotics Tied to Higher Risk of Serious Skin Reactions: Sulfonamides and Cephalosporins Pose Greatest Threat, Study Finds Dr. Garima Soni11 Aug 2024 10:30 PM ISTCanada: Oral antibiotics are linked to a higher risk of serious cutaneous adverse drug reactions (cARDs), as suggested by a current study. The...
Emerging Device-Based Therapies Show Promise for Chronic Pruritus Management: A Comprehensive Review Medha Baranwal9 Aug 2024 8:30 PM ISTSwitzerland: Chronic pruritus, or persistent itching, is a distressing condition that significantly impacts the quality of life for many individuals....
Needle-Free Jet Injector with Bleomycin Proves Effective and Patient-Friendly for Severe Keloids in Recent Study Medha Baranwal8 Aug 2024 8:00 PM ISTNetherlands: A recent study has revealed that Intralesional bleomycin administered via a needle-free electronic pneumatic jet injector (EPI) is...
Platelet-rich plasma effective treatment option for venous ulcers: Study Jacinthlyn Sylvia7 Aug 2024 8:15 AM ISTA new review study published in the recent issue of the Wound Repair and Regeneration journal found study data to support the use of...
